Switzerland · Series A startup

Who invested in POLYNEURON

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$38Mraised across 2 rounds since 2019, from 2 sources

$23MRound$15MSeries A
Latest round
Series A, $15MSept 2020
Biggest round
$23MRound · Mar 2019
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020
$23MRound$15MSeries A
First round
Round, $23M
Mar 2019
Biggest round
$23M
Round · Mar 2019
Between rounds
17 months
from the last two

The rounds

  1. Sept 2020
    Series A$15M1 new2 returning

    Source recorded

  2. Mar 2019

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Sofinnova PartnersVC firm2rounds
Venture KickAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about POLYNEURON

Who invested in POLYNEURON?

POLYNEURON's investors include New Enterprise Associates, Sofinnova Partners and Venture Kick.

How much has POLYNEURON raised?

POLYNEURON has raised $38M across 2 rounds since 2019.

When did POLYNEURON last raise?

POLYNEURON's most recent round was a Series A of $15M in Sept 2020.

What was POLYNEURON's biggest round?

POLYNEURON's largest round on record is $23M (Undisclosed round), in Mar 2019.

Who backed POLYNEURON first?

POLYNEURON's first round on record, in Mar 2019, was backed by New Enterprise Associates and Sofinnova Partners.

What stage is POLYNEURON at?

POLYNEURON's latest named round is a Series A, in Sept 2020.

Where is POLYNEURON based?

POLYNEURON is based in Switzerland.

Companies like POLYNEURON

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.